Abstract: A compound including ligand LA of Formula I, where LA includes at least one deuterium atom is provided. In Formula I, moiety A and B are monocyclic rings or polycyclic fused rings; K1 and K2 are direct bond, O, or S; and either (1) two RA or two RB substituents are joined together to form a fused ring structure of Formula II, where Formula II is joined to ring A or ring B, respectively, by the dashed lines, and Y is Se or GeR?R?; or (2) at least one RA or RB comprises a structure of Formula III, and Y is Se or GeR?R?; where Formula III is not fused to either of ring A or ring B. Formulations, OLEDs, and consumer products including the compound are also provided.

Abstract: A compound that has the structure according to Formula M(LA)x(LB)y(LC)z is disclosed. In Formula M(LA)x(LB)y(LC)z, ligand LA is ligand LB is and ligand LC is and OLEDs and formulations containing these compounds are disclosed. In Formula M(LA)x(LB)y(LC)z: M is a metal; x is 1 or 2; X1-X4 and A1-A8 are C or N; at least one of A1-A8 is N; X is O, S, or Se; two adjacent RB form a six-member aromatic ring E fused to ring B; and each RA-RE and R1-R4 is independently hydrogen or a substituent.

Abstract: A compound comprising a ligand LA of Formula I, is disclosed. In Formula I, ring A is a 5- or 6-membered ring; R is formula II, and is fused to ring B to form ring C; each of X1, X2, X3, and X4 is carbon or nitrogen; X is selected from a variety of bivalent moieties; each R1 to R4, R?, and R? is hydrogen or a substituent; at least one 6-membered ring carbon that is part of Ring A, Ring B, or a fused ring system comprising Ring A or Ring B is substituted with deuterium; and K1 is selected from a direct bond, O, and S. Formulations, OLEDs, and consumer products including the compound are also disclosed.

Abstract: Provided are compounds of formula M(L1)(L2), wherein M is Pd or Pt; L1 is a tridentate ligand, or a substituted or unsubstituted cyclopentadienyl ligand; L2 is a bidentate ligand; if L1 is a tridentate ligand, then it is coordinated to M forming at least two 6-membered chelate rings; if L1 is a cyclopentadienyl ligand, then L2 is a monoanionic ligand; and L1 and L2 can be joined together by a linker. Also provided are formulations comprising these compounds. Further provided are OLEDs and related consumer products that utilize these compounds.

Abstract: Compound of Formula I, is provided. In Formula I, rings A, B, C, and D are 5- or 6-membered rings; each of X1-X5, X21-X22, and Z1-Z3 is C or N; each of L1, L2, and L3 is selected from a direct bond or a divalent linker; each of a and b is 0 or 1; Y is 0, S, Se, or NRY; W is O, S, NRW, C?RW, or CRWRW?; up to 1 of Z1 to Z3 is N; each R, R?, RA, RB, RC, RD, RY, RW, and RW? is hydrogen or a substituent. Formulations, OLEDs, and consumer products containing the same are also disclosed.

Abstract: Novel ligands for metal complexes containing five-membered ring fused on pyridine or pyrimidine ring combined with partially fluorinated side chains exhibiting improved external quantum efficiency and lifetime are disclosed.

Abstract: An OLED including an organic layer that contains metal complex compounds that are useful as a phosphorescent emitter is disclosed. The metal complex compounds include ligands that incorporate fluorinated side chains and has at least one substituent R selected from the group consisting of partially fluorinated alkyl, partially fluorinated cycloalkyl, and combinations thereof, wherein R is directly bonded to an aromatic ring, In the compound, C having an F attached thereto is separated by at least one carbon atom from the aromatic ring.

Abstract: A compound including a first ligand LA of Formula I is disclosed. The compound is useful as an emitter in phosphorescent OLEDs.

Abstract: A compound having a first ligand LA of Formula I is disclosed, where Z1 to Z4 are each independently C or N; at least one of Z1 to Z4 is N; and ring A is a structure of Formula II

Abstract: Provided are organometallic compounds of of Formula I: Also provided are formulations comprising these organometallic compounds. Further provided are OLEDs and related consumer products that utilize these organometallic compounds.

Abstract: Provided are compounds having a ligand LA of Formula I, Also provided are formulations comprising these compounds. Further provided are OLEDs and related consumer products that utilize these compounds.

Abstract: Provided are a compound of Formula I Ir(LA)x(LB)y(LC)z, where x is 1 or 2; y is 1 or 2; z is 0, or 1, with x+y+z=3; LA is a ligand of Formula II

Abstract: A compound comprising a hexadentate ligand of Formula I coordinated to a metal selected from the group consisting of iridium, rhodium, and osmium wherein rings A, D, and E are independently a 5-membered or 6-membered heteroaryl ring, or a 6-membered aryl ring; rings B, C, and F are independently 6-membered heteroaryl ring, or a 6-membered aryl ring; T1, T2, T3, T4, T5, and T6 are independently selected from C or N, wherein two to four of T1 to T6 are C, and two to four of T1 to T6 are N; Z1, Z2, Z3, and Z4 are independently selected from C or N, wherein if Z1 and Z2 are each N then T1 is a carbene carbon and two of T2 to T6 are N; J1 to J11 are independently selected from C or N, wherein if any one of J1 to J4 is N then ring F has no more than three N, if any one of J5 to J7 is N then ring B has no more than three N, or if any one of J8 to J11 is N then is N then ring C has no more than three N; Y1 is selected from the group consisting of CR1, SiR1, B, or N; Y2 is selected from the group consisting of C

Abstract: Provided are organometallic compounds. Also provided are formulations comprising these organometallic compounds. Further provided are OLEDs and related consumer products that utilize these organometallic compounds.

Abstract: Provided is a new class of phosphorescent emitters. The inventive emitters feature a benzimidazole phenoxide ligand, which is connected via “top linkers” to form novel tetradentate ligands. These phosphorescent emitters are Pt tetradentate complexes when used in OLEDs as emitters improves device external quantum efficiency (EQE) and operational lifetimes.

Abstract: A compound of Formula I M is selected from Pd or Pt; X is selected from N or CR3; each R1 and R2, which can be the same or different, and R3, are independently selected from the group consisting of hydrogen, deuterium, halogen, alkoxide, alkyl, cycloalkyl, heteroalkyl, heterocycle, cycloalkene, aryl, heteroaryl, and combinations thereof; wherein at least one of R1, R2, or R3 is selected from the group consisting of: a partially or fully fluorinated alkyl; a partially or fully fluorinated cycloalkyl; and a group of formula A connected to a carbon of one of Y1 to Y4 formula A, wherein Y1, Y2, Y3, and Y4 are independently selected from C or N, and no more than two of Y1 to Y4 is N; and Z is selected from the group consisting of O, S, NR5, and CR6R7. An OLED that includes an organic layer positioned between two electrodes, the organic layer including a compound of Formula I is also described.

Abstract: Provided are organometallic compounds. Also provided are formulations comprising these organometallic compounds. Further provided are OLEDs and related consumer products that utilize these organometallic compounds.

Abstract: Provided are organometallic compounds having a formula Ir(LA)(LB)(LC), wherein: ligand LA is ligand LB is and ligand LC is Also provided are formulations including these organometallic compounds. Further provided are OLEDs and related consumer products that utilize these organometallic compounds.

Abstract: Provided are organometallic compounds comprising a first ligand LA of Formula I Also provided are formulations comprising these organometallic compounds. Further provided are OLEDs and related consumer products that utilize these organometallic compounds.

Abstract: Provided are organometallic complexes including 5-membered heterocyclic rings. The compounds include a ligand LA having a structure of Also provided are formulations comprising these compounds. Further provided are OLEDs and related consumer products that utilize these compounds.